Osteosarcoma (OSA) is the most common cancer of the bone and third most common cancer
diagnosed in children and adolescent. The five-year survival rate for OSA patients …

Osteosarcoma is the most common bone tumor in children and young adults, with few
advances in survival and treatment, especially for metastatic disease, in the last 30 years …

Osteosarcoma (OS) is the most common primary malignant bone sarcoma mainly affecting
adolescents and young adults, which often progresses to pulmonary metastasis and leads to …

Osteosarcoma (OS) is the most common primary bone cancer affecting children and young
adults, most often occurring at the metaphysis of long bones. At present, treatment with …

Osteosarcoma (OS) is a highly malignant tumor occurring in bone tissue with a high
propensity to metastasize, and its underlying mechanisms remain largely elusive. The OS …

Osteosarcoma is the most common primary bone cancer in children and young adults.
Limited progress has been made in improving the survival outcomes in patients with …

Osteosarcoma (OS) is a highly malignant tumor occurring in bone tissue with a high
propensity to metastasize, and its underlying mechanisms remain largely elusive. The OS …

Osteosarcoma is the most prevalent bone tumor in children, adolescents, and young adults.
It is considered a systemic disease with micrometastatic spread present already at …

T-cell immunotherapy may offer an approach to improve outcomes for patients with
osteosarcoma who fail current therapies. In addition, it has the potential to reduce treatment …

The cure rate for metastatic or relapsed osteosarcoma has not substantially improved over
the past decades despite the exploitation of multimodal treatment approaches, allowing long …